Table 1 Baseline Demographic and Postoperative Characteristics of Patients Who Underwent Robotic or Laparoscopic Surgery
Characteristic | RDG (n = 141) | LDG (n = 142) |
|---|---|---|
Mean ± SD/N (%) | Mean ± SD/N (%) | |
Age, y | 59.4 ± 10.2 | 59.3 ± 11.3 |
BMI, kg/m2 | 23.2 ± 3.0 | 22.7 ± 3.3 |
Tumor size, mm | 35.1 ± 17.9 | 39.3 ± 19.6 |
Sex | ||
Male | 94 (66.7%) | 90 (63.4%) |
Female | 47 (33.3%) | 52 (36.6%) |
ECOG PS | ||
0 | 116 (82.3%) | 111 (78.2%) |
1 | 25 (17.7%) | 31 (21.8%) |
Histology | ||
Differentiated | 52 (36.9%) | 56 (39.4%) |
Undifferentiated | 89 (63.1%) | 86 (60.6%) |
Lymphovascular invasion | ||
Negative | 81 (57.4%) | 76 (53.5%) |
Positive | 60 (42.6%) | 66 (46.5%) |
cT stage | ||
cT1-T3 | 94 (66.7%) | 83 (58.5%) |
cT4 | 47 (33.3%) | 59 (41.5%) |
cN stage | ||
cN0 | 63 (44.7%) | 58 (40.8%) |
cN+ | 78 (55.3%) | 84 (59.2%) |
pT stage | ||
pT1 | 55 (39.0%) | 37 (26.1%) |
pT2 | 23 (16.3%) | 19 (13.4%) |
pT3 | 45 (31.9%) | 59 (41.5%) |
pT4 | 18 (12.8%) | 27 (19.0%) |
pN stage | ||
pN0 | 54 (38.3%) | 56 (39.4%) |
pN1 | 26 (18.4%) | 22 (15.5%) |
pN2 | 28 (19.9%) | 27 (19.0%) |
pN3a | 23 (16.3%) | 22 (15.5%) |
pN3b | 10 (7.1%) | 15 (10.6%) |
AJCC8th pTNM stage | ||
I | 55 (39.0%) | 43 (30.3%) |
II | 33 (23.4%) | 36 (25.4%) |
III | 53 (37.6%) | 63 (44.4%) |
